Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.9104
+0.0121 (1.35%)
At close: Feb 25, 2026, 4:00 PM EST
0.9100
-0.0004 (-0.04%)
After-hours: Feb 25, 2026, 5:19 PM EST
Immunic Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
90
Market Cap
118.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 127.63M |
| Fortress Biotech | 62.30M |
| Spero Therapeutics | 40.55M |
| Seer, Inc. | 16.38M |
| Korro Bio | 7.37M |
| Equillium | 4.39M |
| Coya Therapeutics | 3.99M |
| Cardiff Oncology | 593.00K |
IMUX News
- 8 days ago - Immunic Announces Closing of Oversubscribed Private Placement Financing - PRNewsWire
- 12 days ago - Immunic Stock Jumps After Pricing $400 Million Private Placement - Benzinga
- 12 days ago - Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company - PRNewsWire
- 21 days ago - Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis - PRNewsWire
- 7 weeks ago - Immunic Highlights 2025 Accomplishments and Upcoming Milestones - PRNewsWire
- 3 months ago - Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - PRNewsWire
- 3 months ago - Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Immunic to Participate in Industry and Investor Conferences in November - PRNewsWire